First, UTUC has a relatively low incidence rate, but it is aggressive and affected patients have a relatively poor prognosis.[41] It is possible that E-cadherin may not stand out because patients with UTUC have a poor prognosis due to the strong aggressiveness of the carcinoma. The gene discussed is CDH1; the disease is renal pelvis/ureter urothelial carcinoma.